|Product Overview :||Recombinant Human CD248(Gln18-Arg685) fused with His tag at C-terminal was expressed in NS0.|
|Predicted N Terminal :||Gln18 predicted: No results obtained, sequencing might be blocked|
|Form :||Lyophilized from a 0.2 μm filtered solution in PBS.|
|Bio-activity :||Measured by its binding ability in a functional ELISA. When Recombinant Human Endosialin/CD248 is immobilized at 2 μg/mL (100 μL/well), the concentration of Recombinant Human Galectin‑3BP/MAC‑2BP that produces 50% of the optimal binding response is approximately 0.08-0.4 μg/mL.|
|Molecular Mass :||Predicted Molecular Mass: 72 kDa;
SDS-PAGE: 110-150 kDa, reducing conditions.
|Protein length :||Gln18-Arg685|
|Endotoxin :||<0.10 EU per 1 μg of the protein by the LAL method.|
|Purity :||>95%, by SDS-PAGE under reducing conditions and visualized by silver stain|
|Storage :||Avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 centigrade as supplied.
1 month, 2 to 8 centigrade under sterile conditions after reconstitution.
3 months, -20 to -70 centigrade under sterile conditions after reconstitution.
|Reconstitution :||Reconstitute at 100 μg/mL in PBS.|
|Gene Name :||CD248 CD248 molecule, endosialin [ Homo sapiens ]|
|Official Symbol :||CD248|
|Synonyms :||CD248; CD248 molecule, endosialin; CD164 sialomucin like 1 , CD164L1, CD248 antigen, endosialin; endosialin; TEM1; tumor endothelial marker 1; 2610111G01Rik; CD164 sialomucin-like 1; CD248 antigen, endosialin; CD164L1; MGC119478; MGC119479;|
|Gene ID :||57124|
|mRNA Refseq :||NM_020404|
|Protein Refseq :||NP_065137|
|UniProt ID :||Q9HCU0|